1 hour agoBusiness
27LENS
5 SourcesMumbai, India
thebalanced.newsAlembic Pharmaceuticals Reports 29% Q4 Profit Increase and Revenue Growth in FY26
Alembic Pharmaceuticals reported a 29% year-on-year rise in consolidated net profit to Rs 202.7 crore for Q4 FY26, with revenue increasing 4.4% to Rs 1,847.7 crore. Full-year revenue reached Rs 7,344.9 crore, up from Rs 6,672.1 crore, and net profit rose to Rs 674.8 crore. The quarter saw higher expenses due to employee benefits and operational costs, alongside deferred tax credits and exceptional charges. Growth was supported by US market product launches and expansion in branded and international segments.
Political Bias
0%100%0%
Sentiment
73%
AI Analysis
Political bias across 5 sources
● Left 0%● Center 100%● Right 0%
The articles primarily present corporate financial results without political framing. Coverage focuses on Alembic Pharmaceuticals' business performance, operational details, and market activities. Perspectives include company statements and financial data, with no evident political viewpoints or partisan interpretations, reflecting a neutral business reporting approach.
Sentiment — Positive (73/100)
The overall tone is positive, emphasizing profit growth, revenue increases, and strategic business developments. While some articles note higher expenses and exceptional charges, the sentiment remains constructive, highlighting operational achievements and future growth prospects without critical or negative language.
How 5 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| businessstandard | Alembic Pharmaceuticals consolidated net profit rises 29.20 in the March 2026 quarter | Center | Positive |
| moneycontrol | Alembic Pharma Consolidated March 2026 Net Sales at Rs 1,847.72 crore, up 4.41 Y-o-Y- Moneycontrol.com | Center | Positive |
| news18 | Alembic Pharmaceuticals Q4 net profit rises 29 pc at Rs 202.7 cr | Center | Positive |
| businessstandard | Alembic Pharma gains after Q4 PAT climbs 29 YoY to Rs 203 cr | Center | Positive |
| freepressjournal | Alembic Pharmaceuticals Q4 Profit Jumps 29 To 203 Crore, FY26 Revenue Crosses 7,344 Crore | Center | Positive |
Coverage timeline
freepressjournal broke this story on 15 May, 10:02 am. Other outlets followed.
- 1freepressjournal15 May, 10:02 amAlembic Pharmaceuticals Q4 Profit Jumps 29 To 203 Crore, FY26 Revenue Crosses 7,344 Crore
- 2businessstandard15 May, 10:28 amAlembic Pharma gains after Q4 PAT climbs 29 YoY to Rs 203 cr
- 3news1815 May, 10:33 amAlembic Pharmaceuticals Q4 net profit rises 29 pc at Rs 202.7 cr
- 4moneycontrol15 May, 10:34 amAlembic Pharma Consolidated March 2026 Net Sales at Rs 1,847.72 crore, up 4.41 Y-o-Y- Moneycontrol.com
- 5businessstandard15 May, 11:16 amAlembic Pharmaceuticals consolidated net profit rises 29.20 in the March 2026 quarter
Lens Score breakdown
27/100
Public interest0/100
Coverage gap100%
Well-covered story — coverage matches public importance.
Who's involved
Institutions and figures named across source coverage.
Corporate
Alembic PharmaceuticalsAlembic Pharmaceuticals Limited
Story context
- Category
- Business
- Location
- Mumbai, India
- Sources analysed
- 5
- Last analysed
- 15 May 2026
- Key entities
- CroreIndian rupeeAlembic PharmaceuticalsAlembic IncNet incomeRevenueNational Stock Exchange of IndiaDeferred taxMumbaiEarnings per shareFiscal yearDividend
Related Coverage
Select a news story to see related coverage from other media outlets.